Sphere Medical Holding PLC (LON:SPHR)‘s stock had its “buy” rating reaffirmed by analysts at Panmure Gordon in a note issued to investors on Friday. They currently have a GBX 17 ($0.22) price objective on the stock. Panmure Gordon’s price target points to a potential upside of 47.83% from the company’s current price.

Sphere Medical Holding PLC (LON:SPHR) opened at 11.49501 on Friday. Sphere Medical Holding PLC has a 1-year low of GBX 6.00 and a 1-year high of GBX 15.00. The firm’s market capitalization is GBX 16.29 million. The company has a 50-day moving average price of GBX 11.63 and a 200 day moving average price of GBX 11.09.

Sphere Medical Holding PLC Company Profile

Sphere Medical Holding PLC is a United Kingdom-based Company specializing in the development of medical monitoring and diagnostic equipment. The Company’s products include Proxima and Pelorus. Proxima is an arterial blood gas analyser which supports rapid and frequent measurement. It is operated using the dedicated bedside monitor with touch screen interface.

Receive News & Stock Ratings for Sphere Medical Holding PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sphere Medical Holding PLC and related stocks with our FREE daily email newsletter.